Paul Hastings LLP advised GenScript Biotech Corporation and and its subsidiary Probio Technology Limited on the deal. GenScript ProBio announced its Series C round of financing...
Probio’s Series C Financing
Model Performance Acquisition Corp’s de-SPAC Merger with MultiMetaVerse Inc.
Ogier and Loeb & Loeb LLP assisted Model Performance Acquisition Corp in its de-SPAC merger with MultiMetaVerse Inc., represented by Paul Hastings LLP. MultiMetaVerse Inc., an...
Mega Genomics’ HK$215 Million IPO
Paul Hastings and Appleby advised Mega Genomics Limited on the deal while Sidley represented China Securities. Mega Genomics Limited, the largest consumer genetic testing platform in...
Hillhouse’s Investment in GenScript Biotech Corporation
Paul Hastings advised GenScript Biotech Corporatio on the deal. GenScript Biotech Corporation (HKEX Stock Code: 1548.HK) and its indirect wholly-owned subsidiary Probio Technology Limited (“Probio”) announced a Series...